Authors: Louvet, C Andre, T Hammel, P Selle, F Landi, B Cattan, S Fonck, M Flesch, M Colin, P Balosso, J Ruszniewski, P de Gramont, A

Citation: C. Louvet et al., Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM), ANN ONCOL, 12(5), 2001, pp. 675-679

Authors: Moscatelli, MC Fonck, M De Angelis, P Larbi, H Macuz, A Rambelli, A Grego, S

Citation: Mc. Moscatelli et al., Mediterranean natural forest living at elevated carbon dioxide: soil biological properties and plant biomass growth., SOIL USE M, 17(3), 2001, pp. 195-202

Authors: Valla, DC Chevallier, M Marcellin, P Payen, JL Trepo, C Fonck, M Bourliere, M Boucher, E Miguet, JP Parlier, D Lemonnier, C Opolon, P

Citation: Dc. Valla et al., Treatment of hepatitis c virus-related cirrhosis: A randomized, controlledtrial of interferon alfa-2b versus no treatment, HEPATOLOGY, 29(6), 1999, pp. 1870-1875

Authors: Brunet, R Fonck, M

Citation: R. Brunet et M. Fonck, Advantage of gemcitabine in the treatment of advanced pancreatic carcinoma., REV MED IN, 20(9), 1999, pp. 816-820